Excerpt:

Whispers of stock ‘dying suddenly’ will no doubt become a complaint of farmers in the future, summarily ignored by government in the same way officials refuse to listen to serious concerns about dam-building restrictions, price hikes on Ag products, ridiculous fees and charges, incomprehensible red and green tape, biosecurity regulations that do nothing, and – fresh out of Western Australia – expensive negotiations with Indigenous groups who have never set foot on the land they claim to ‘own’.

In one example that mRNA is on its way Down Under, on May 2, 2023, Meat and Livestock Australia (MLA) announced funding for a project to ‘test mRNA vaccines that can be rapidly mass-produced in Australia in the event of a lumpy skin disease or other exotic disease outbreak’.

The Manager for Animal Wellbeing, released a statement saying:

‘This project will develop a mRNA vaccine pipeline initially for LSD, but potentially for other emergency diseases. This will enable capacity for rapid mass production of a vaccine for LSD in the event of an outbreak. No LSD vaccines are registered for use in Australia yet. While some vaccines exist overseas, the path to registration in Australia for traditionally-produced [vaccines] is longer than that of an mRNA vaccine.’

Why are traditional vaccines, which have safety records that outstrip mRNA vaccines, subject to longer approval periods than mRNA vaccines? That sounds like a significant structural failure within Australia’s health body that, instead of being fixed, has the potential to be exploited by manufacturers looking to cash in on mRNA.

mRNA vaccines are quick to produce and ‘nimble’, which is why pharmaceutical companies like them – but that doesn’t mean that they are safe, effective, or suitable for consumers whether those are humans or livestock.

...